Fox Chase Cancer Center to Offer Sequencing Services to Cancer Patients on LifeTech's SOLiD
June 15, 2011
Fox Chase Cancer Center to Offer Sequencing Services to Cancer Patients on LifeTech's SOLiD
The goal is to use sequencing to help identify drugs that could target patients' specific mutations and to rule out drugs that likely would not be effective.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Switching from SOLiD to PGM, Fox Chase Adopts Targeted Sequencing for Cancer Patients
December 21, 2011 / Clinical Sequencing News - Fox Chase Debuts CancerCode-45 Test Based on Adapted Ion Torrent AmpliSeq Panel
January 16, 2013 / Clinical Sequencing News - $30M Fundraising Goal Set for Launching, Equipping Cancer Genome Institute at Fox Chase
November 18, 2010 / GenomeWeb Daily News - Life Technologies, Research Partners Launch Cancer Care Alliance
June 4, 2010 / GenomeWeb Daily News - Asuragen Launches Cancer Panels Optimized for FFPE Tissue; Plans to Sell Proprietary Reagents
April 10, 2013 / Clinical Sequencing News